| Management number | 231846378 | Release Date | 2026/06/18 | List Price | US$20.96 | Model Number | 231846378 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Develop Effective Immunogenicity Risk Mitigation StrategiesImmunogenicity assessment is a prerequisite for the successful development of biopharmaceuticals, including safety and efficacy evaluation. Using advanced statistical methods in the study design and analysis stages is therefore essential to immunogenicity risk assessment and mitigation stra Read more
| ASIN | B07NPSM6ZK |
|---|---|
| XRay | Not Enabled |
| Format | Print Replica |
| ISBN13 | 978-1498700351 |
| Edition | 1st |
| Language | English |
| File size | 7.9 MB |
| Page Flip | Not Enabled |
| Publisher | Chapman and Hall/CRC |
| Word Wise | Not Enabled |
| Print length | 258 pages |
| Accessibility | Learn more |
| Part of series | Chapman & Hall/CRC Biostatistics |
| Publication date | July 17, 2015 |
| Enhanced typesetting | Not Enabled |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form